MacroNYT BusinessApr 24, 2026· 1 min read
Trump-Era HSA Expansion Raises Conflict Concerns for RFK Jr. Aide

Calley Means, a current RFK Jr. aide, presided over a wellness company reliant on Health Savings Accounts (HSAs) as the Trump administration actively pursued policies to expand them. This situation highlights potential economic conflicts given the direct benefit his company stood to gain from the proposed HSA expansions.
During the Trump administration's active development of policies to expand Health Savings Accounts (HSAs), Calley Means, now a senior advisor to Robert F. Kennedy Jr.'s presidential campaign, maintained his role as president of a wellness company that heavily utilized these accounts. This intersection raises questions about potential conflicts of interest as the administration championed the very financial mechanisms central to Means' company's business model.
The Trump administration, particularly in 2023, pursued a significant push to broaden the scope and utility of HSAs, presenting them as a market-driven solution to healthcare costs. Policies under consideration aimed to increase contribution limits, expand eligible expenses, and generally make HSAs a more central component of individual health financing. Such expansions would directly benefit companies whose services and products are commonly purchased using HSA funds, by enlarging the pool of potential customers and increasing their available spending power.
Means' company, which operates in the wellness sector, relies on consumers leveraging HSAs to pay for its offerings. A larger and more accessible HSA market directly translates to an enhanced commercial environment for such enterprises. While the report does not detail Means' specific involvement in policy discussions, his simultaneous leadership of a company poised for significant gains from these policy shifts highlights an economic dynamic worth noting.
From an economic perspective, the expansion of HSAs generally seeks to empower consumers with more control over their healthcare spending and potentially reduce reliance on traditional insurance. However, the private sector's influence on such policy development, particularly when individuals with direct commercial interests are involved, warrants scrutiny. The scenario underscores the constant tension between public policy objectives and private economic interests in the healthcare landscape.